• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面对面和基于远程治疗的扩展版李氏言语治疗法(LOUD)对脑瘫成人构音障碍和吞咽困难的疗效。

Efficacy of in-person and telepractice-based extended Lee Silverman Voice Treatment LOUD on dysarthria and dysphagia in adults with cerebral palsy.

作者信息

Kim Kyung Min, Park Sang Ah, Hwang Seong Hye, Park Alyssia, Kim Hyang Hee, Hwang Jihye, Cho Sung-Rae

机构信息

Department of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Digit Health. 2025 Jan 31;11:20552076251315296. doi: 10.1177/20552076251315296. eCollection 2025 Jan-Dec.

DOI:10.1177/20552076251315296
PMID:39896269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786291/
Abstract

OBJECTIVE

With advancements in digital health technologies, telepractice has become crucial for providing accessible medical interventions. Cerebral palsy (CP) frequently results in comorbidities including dysarthria and dysphagia, leading to restrictions in activities. This study evaluates the efficacy of both in-person and telepractice-based intensive voice therapy in improving speech, swallowing functions, and related quality of life measures in adults with CP.

METHODS

The Lee Silverman Voice Treatment (LSVT) LOUD, a speech-behavior therapy, was administered to 16 CP subjects (9 men and 7 women; mean age = 43.4 ± 10.43 years) via in-person extended version of LSVT LOUD (LSVT-X), and telepractice program of LSVT-X (LSVT-X e-LOUD). Outcomes, including maximum phonation time (MPT), voice intensity, diadochokinetic rate (DDK), Voice Handicap Index (VHI), swallowing quality of life (SWAL-QOL), and Videofluoroscopic Dysphagia Scale (VDS), were assessed pre- and post-treatment.

RESULTS

Significant improvements were noted in speech functions: MPT (= 0.006), voice intensity (= 0.004), DDK /puh/ (= 0.043), and DDK/puh-tuh-kuh/ (= 0.031). Swallowing function improved significantly in the pharyngeal phase on the VDS. Quality of life measures showed improvement in physical (= 0.003), emotional (= 0.000), total score of VHI (= 0.001), fear (= 0.031), sleep (= 0.013), fatigue (= 0.003), and total score of SWAL-QOL (= 0.019). These improvements were consistent in both LSVT-X and LSVT-X e-LOUD groups.

CONCLUSIONS

Both in-person and telepractice-based LSVT-X enhance speech, swallowing functions, and quality of life in adults with CP. LSVT-X e-LOUD can be utilized as a digital therapeutic intervention for dysphagia and dysarthria, offering accessible and flexible treatment options aligned with digital health advancements.

摘要

目的

随着数字健康技术的进步,远程医疗实践对于提供可及的医疗干预变得至关重要。脑瘫(CP)常伴有构音障碍和吞咽困难等合并症,导致活动受限。本研究评估面对面和基于远程医疗实践的强化嗓音治疗对改善成年脑瘫患者的言语、吞咽功能及相关生活质量指标的疗效。

方法

对16名脑瘫受试者(9名男性和7名女性;平均年龄 = 43.4 ± 10.43岁)实施言语行为疗法李·西尔弗曼嗓音治疗(LSVT)LOUD,通过LSVT LOUD的面对面扩展版(LSVT-X)和LSVT-X的远程医疗实践项目(LSVT-X e-LOUD)进行。在治疗前后评估各项指标,包括最长发声时间(MPT)语音强度、重复发声率(DDK)、嗓音障碍指数(VHI)、吞咽生活质量(SWAL-QOL)和电视荧光吞咽造影评分(VDS)。

结果

言语功能有显著改善:MPT(= 0.006)、语音强度(= 0.004)、DDK /puh/(= 0.043)和DDK/puh-tuh-kuh/(= 0.031)。VDS显示吞咽功能在咽期有显著改善。生活质量指标显示身体方面(= 0.003)、情感方面(= 0.000)、VHI总分(= 0.001)、恐惧(= 0.031)、睡眠(= 0.013)、疲劳(= 0.003)和SWAL-QOL总分(= 0.019)均有改善。这些改善在LSVT-X组和LSVT-X e-LOUD组中均一致。

结论

面对面和基于远程医疗实践的LSVT-X均可改善成年脑瘫患者的言语、吞咽功能及生活质量。LSVT-X e-LOUD可作为吞咽困难和构音障碍的数字治疗干预手段,提供与数字健康进步相契合且可及、灵活的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f5/11786291/0f7648bed342/10.1177_20552076251315296-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f5/11786291/0f7648bed342/10.1177_20552076251315296-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f5/11786291/0f7648bed342/10.1177_20552076251315296-fig1.jpg

相似文献

1
Efficacy of in-person and telepractice-based extended Lee Silverman Voice Treatment LOUD on dysarthria and dysphagia in adults with cerebral palsy.面对面和基于远程治疗的扩展版李氏言语治疗法(LOUD)对脑瘫成人构音障碍和吞咽困难的疗效。
Digit Health. 2025 Jan 31;11:20552076251315296. doi: 10.1177/20552076251315296. eCollection 2025 Jan-Dec.
2
Swallowing Outcomes Following Voice Therapy in Multiple System Atrophy with Dysphagia: Comparison of Treatment Efficacy with Parkinson's Disease.多系统萎缩伴吞咽困难患者行嗓音治疗后的吞咽结局:与帕金森病的疗效比较。
Dysphagia. 2022 Feb;37(1):198-206. doi: 10.1007/s00455-021-10265-9. Epub 2021 Mar 5.
3
Intensive voice treatment (the Lee Silverman Voice Treatment [LSVTLOUD]) for individuals with Wilson's disease and adult cerebral palsy: two case reports.Wilson 病和成人脑瘫患者的强化嗓音治疗(Lee Silverman 嗓音治疗[LSVTLOUD]):两例病例报告。
Logoped Phoniatr Vocol. 2022 Dec;47(4):262-270. doi: 10.1080/14015439.2021.1951348. Epub 2021 Jul 21.
4
Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.李·西尔曼嗓音治疗(LSVT LOUD®)对帕金森病吞咽和咳嗽的影响:一项初步研究。
J Neurol Sci. 2017 Dec 15;383:180-187. doi: 10.1016/j.jns.2017.11.015. Epub 2017 Nov 15.
5
Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study.李·西尔弗曼嗓音治疗法(LSVT LOUD)对进行性核上性麻痹患者吞咽功能的影响:一项初步研究。
Prog Rehabil Med. 2021 Feb 20;6:20210012. doi: 10.2490/prm.20210012. eCollection 2021.
6
Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.多发性硬化症患者强化嗓音治疗(李·西尔弗曼嗓音治疗 [LSVT LOUD])的效果:一项初步研究。
J Voice. 2022 Jul;36(4):585.e1-585.e13. doi: 10.1016/j.jvoice.2020.07.025. Epub 2020 Aug 18.
7
Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson's disease: a pilot randomised controlled trial.使用LSVT®Coach对帕金森病患者进行面对面和在线LSVT®LOUD言语训练的比较:一项试点随机对照试验。
BMC Neurol. 2025 Apr 26;25(1):183. doi: 10.1186/s12883-025-04161-0.
8
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.李·西尔弗曼语音治疗与英国国民保健制度(NHS)言语和语言治疗对照治疗帕金森病(PD COMM)患者构音障碍的实用性、基于英国、多中心、三臂、平行组、非盲、随机对照试验。
BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341.
9
Therapeutic effects of intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria: A phase I treatment validation study.强化嗓音治疗(LSVT LOUD)对痉挛型脑瘫和构音障碍儿童的治疗效果:一项I期治疗验证研究。
Int J Speech Lang Pathol. 2017 Dec;19(6):601-615. doi: 10.1080/17549507.2016.1221451. Epub 2016 Oct 5.
10
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.一项多中心、随机对照试验,旨在比较李·西尔弗曼嗓音治疗与标准国民保健制度语音和语言治疗与对照组在帕金森病中的临床和成本效益:一项随机对照试验的研究方案。
Trials. 2020 May 27;21(1):436. doi: 10.1186/s13063-020-04354-7.

本文引用的文献

1
A Narrative Review of Current Status and Future Perspective of Telemedicine for Parkinson's Disease, Dementia, and Intractable Neurological Diseases in Japan.日本帕金森病、痴呆症及难治性神经系统疾病远程医疗的现状与未来展望述评
Juntendo Iji Zasshi. 2023 Jan 26;69(1):14-20. doi: 10.14789/jmj.JMJ22-0031-R. eCollection 2023.
2
Cost-Analysis of Telemedicine Interventions Compared with Traditional Care in the Management of Chronic Neurological Diseases: A Systematic Review.远程医疗干预与传统护理在慢性神经系统疾病管理中的成本分析:系统评价。
Telemed J E Health. 2024 Feb;30(2):404-414. doi: 10.1089/tmj.2023.0106. Epub 2023 Jul 19.
3
Telemedicine for neurological diseases: A systematic review and meta-analysis.
神经系统疾病的远程医疗:一项系统评价与荟萃分析。
Eur J Neurol. 2023 Jan;30(1):241-254. doi: 10.1111/ene.15599. Epub 2022 Nov 14.
4
Telemedicine in neurology: advances and possibilities.神经病学中的远程医疗:进展与可能。
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):336-341. doi: 10.1590/0004-282X-ANP-2022-S127.
5
The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study.**新冠疫情期间远程医疗使用的模式和决定因素:一项全国性研究。**
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1778-1785. doi: 10.1016/j.japh.2022.05.020. Epub 2022 May 28.
6
Intensive voice treatment (the Lee Silverman Voice Treatment [LSVTLOUD]) for individuals with Wilson's disease and adult cerebral palsy: two case reports.Wilson 病和成人脑瘫患者的强化嗓音治疗(Lee Silverman 嗓音治疗[LSVTLOUD]):两例病例报告。
Logoped Phoniatr Vocol. 2022 Dec;47(4):262-270. doi: 10.1080/14015439.2021.1951348. Epub 2021 Jul 21.
7
Swallowing Outcomes Following Voice Therapy in Multiple System Atrophy with Dysphagia: Comparison of Treatment Efficacy with Parkinson's Disease.多系统萎缩伴吞咽困难患者行嗓音治疗后的吞咽结局:与帕金森病的疗效比较。
Dysphagia. 2022 Feb;37(1):198-206. doi: 10.1007/s00455-021-10265-9. Epub 2021 Mar 5.
8
The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.李西尔曼嗓音治疗(LSVT LOUD®)对嗓音、交流和参与度的影响:来自前瞻性、纵向研究的结果。
J Commun Disord. 2021 Jan-Feb;89:106031. doi: 10.1016/j.jcomdis.2020.106031. Epub 2020 Aug 18.
9
The Need for Digital Health Solutions in Deep Brain Stimulation for Parkinson's Disease in the Time of COVID-19 and Beyond.数字健康解决方案在 COVID-19 时期及之后帕金森病深部脑刺激中的必要性。
Neuromodulation. 2021 Feb;24(2):331-336. doi: 10.1111/ner.13307. Epub 2020 Nov 10.
10
Investigating the Accessibility of Voice Assistants With Impaired Users: Mixed Methods Study.调查残障用户对语音助手的可及性:混合方法研究。
J Med Internet Res. 2020 Sep 25;22(9):e18431. doi: 10.2196/18431.